Shares of Celadon Pharmaceuticals Plc (LON:CEL – Get Free Report) were up 14% during trading on Wednesday . The company traded as high as GBX 3.42 ($0.04) and last traded at GBX 3.42 ($0.04). Approximately 275,744 shares changed hands during mid-day trading, an increase of 1% from the average daily volume of 274,066 shares. The stock had previously closed at GBX 3 ($0.04).
Celadon Pharmaceuticals Price Performance
The business has a 50 day moving average of GBX 16.50 and a 200 day moving average of GBX 20.98. The company has a market cap of £2.10 million, a PE ratio of -0.43 and a beta of -0.26. The company has a debt-to-equity ratio of 196.67, a current ratio of 1.92 and a quick ratio of 6.97.
Celadon Pharmaceuticals Company Profile
Celadon Pharmaceuticals Plc is a UK-based pharmaceutical company focused on the development, production and sale of breakthrough cannabis-based medicines. Its primary focus is on improving quality of life for chronic pain sufferers, as well as exploring the potential of cannabis-based medicines for other conditions such as autism.
Featured Articles
- Five stocks we like better than Celadon Pharmaceuticals
- What Are the FAANG Stocks and Are They Good Investments?
- Will 2025 Be the Year the Energy Sector Finally Breaks Out?
- What Are Some of the Best Large-Cap Stocks to Buy?
- NextEra Energy Stock Sees Spike in Bullish Call Activity
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Top 3 Stocks Mega Investors Are Buying Now
Receive News & Ratings for Celadon Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celadon Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
